Literature DB >> 572479

Bioavailability of oral antibiotics in cystic fibrosis.

J P Guggenbichler, G Kienel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 572479

Source DB:  PubMed          Journal:  Monogr Paediatr        ISSN： 0077-0914


× No keyword cloud information.
  10 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  The tubular excretion of benzylpenicillin in patients with cystic fibrosis.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 5.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

6.  Pharmacokinetics of netilmicin in children with and without cystic fibrosis.

Authors:  H Michalsen; T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

7.  Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis.

Authors:  R Demnati; M C Michoud; A Jeanneret-Grosjean; H Ong; P Du Souich
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics in infants and children. A reappraisal.

Authors:  G L Kearns; M D Reed
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

9.  Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

Authors:  B A Christensson; I Nilsson-Ehle; B Ljungberg; A Lindblad; A S Malmborg; L Hjelte; B Strandvik
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  Antimicrobial chemotherapy in patients with cystic fibrosis.

Authors:  J P Guggenbichler; J Schneeberger
Journal:  Infection       Date:  1987       Impact factor: 3.553
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.